New Quantum Indices for Macromolecular Characterization

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Insights into the amazing world of RNA catalysis from hybrid QM/MM simulations Darrin M. York http://theory.rutgers.edu RNA catalysis is important from a fundamental biological and evolutionary perspective 1989 Nobel Prize in Chemistry: Thomas R. Cech and Sidney Altman for their "discovery of catalytic properties of RNA”. The 2009 Nobel Prize in Chemistry: Venkatraman Ramakrishnan, Thomas A. Steitz and Ada E. Yonath for “studies of the structure and function of the ribosome”. RNA catalysis is chemically interesting! Unlike protein enzymes, the (4.2) repertoire of building blocks and chemical functional groups available for catalysis in RNA is (9.2) limited: • 4 relatively inert nucleobases • Stable sugar-phosphate backbone (3.5) • Solution pKa values shifted relatively far from neutrality • Each phosphate carries -1 charge (no other charged (9.5) groups at neutral pH) Fundamental question as to how RNA molecules can adopt 3D structures that confer enzyme activity at all. RNA catalysis is chemically interesting! Naturally Occurring Ribozymes Site-specific phosphoryl transfer (O2’-transphosphorylation) - Hammerhead, HDV, Hairpin, VS, glmS, Twister, TS, pistol, RNase P… Site-specific intermolecular phosphoryl transfer (exogenous O3’ attack) - Group I and II intron Peptidyl/Amino-acyl transfer - Ribosome (RNA active site core) In vitro evolved/synthetic ribozymes Diels-Alder cycloaddition Michael addition Aldol condensation RNA polymerization - class I RNA ligase (e.g., L1 ligase) RNA catalysis has had impact on biotechnology • Biotechnology Tools − gene expression − medical diagnostics − biosensors − drug discovery Ribozymes are less efficient than protein enzymes – but that might just be their biggest advantage… • Whereas the overall rate enhancement for the fastest protein enzymes exceed that of RNA enzymes, there is growing precedent that the intrinsic catalytic rate may be more similar The image part with relationship ID rId2 was not found in the file. • Formation of a catalytically active state in RNA is often an improbable event that is highly sensitive control factors (conformational state, metal ion/cofactor binding, pH, etc…) – although this limits efficiency, it is a tremendous design advantage! Key Concepts Garcia-Viloca et al. Science, 303, 184 (2004) Why is free energy and sampling important in the study of RNA catalysis? • To characterize the catalytically active state in solution • To explore the free energy landscape of the chemical reaction • To aid in the interpretation of experiments and make predictions • The goal is not to (just) predict rate or even pathway – it is to gain a predictive understanding of mechanism in order to guide design Complexity of the “Problem Space” for RNA Catalysis RNA catalysis departs from a active state defined by: 1) Conformation (ζ∗) 2) Metal ion binding mode (M*) 3) Protonation state (p*) These elements are intimately coupled, creating a highly complex “problem space” that must be addressed prior to any investigation of the chemical steps of the catalytic mechanism. Typically the only part that QM/MM studies address Computational RNA Enzymology What is a quantum mechanical force field (QMFF)? • Quantum mechanical force fields (QMFFs) are a specific class of linear-scaling quantum mechanical (LSQM) methods that replace elements of theoretical rigor by introducing parametrically fitted functions to achieve higher accuracy and computational. • QMFFs use a fragmentation approach and empirical density- functional interactions that avoid explicit inter-fragment orbital coupling. • QMFFs leverage the benefits provided by the LSQM and QM/MM approaches to produce a fully QM method that is able to simultaneously achieve very high accuracy and efficiency. Acc. Chem. Res. (2014) 47, 2812–2820. J. Chem. Theory Comput. 11, 436 (2015); 11, 451 (2015). J. Phys. Condens. Matter (Topical Review) 29, 383002 (2017). QMFF Framework - Algorithm Differences Acc. Chem. Res. (2014) 47, 2812–2820. J. Chem. Theory Comput. 11, 436 (2015); 11, 451 (2015). J. Phys. Condens. Matter (Topical Review) 29, 383002 (2017). Electrostatic Potential Difference Maps (Reference: B3LYP/6-311++G**) DFTB3 Electrostatic Potential Difference Maps (Reference: B3LYP/6-311++G**) mDC DFTB3 Unlike DFTB3 mDC uses multipoles for improved electrostatics and hydrogen bonding. Errors in non-bonded interactions are better than DFTB3 or dispersion-corrected DFT functionals tested, and give excellent results in condensed phase simulations so far… Next-generation QMFFs Protein-protein interactions, simulations in the condensed phase (solution and crystals). Next-generation QMFFs Acc. Chem. Res. (2014) 47, 2812–2820. J. Chem. Theory Comput. 11, 436 (2015); 11, 451 (2015). Next-generation QMFFs J. Chem. Theory Comput. 11, 436 (2015); 11, 451 (2015). Next-generation QMFFs J. Chem. Theory Comput. 11, 436 (2015); 11, 451 (2015). Next-generation QMFFs Reference data: J. Chem. Theory Comput. 5, 1016 (2009). Acc. Chem. Res. 47, 2812 (2014). J. Chem. Theory Comput. 11, 436 (2015); 11, 451 (2015). DFTB3: SCF procedure with 60X speed up (1 sec = 1 min) mDC: SCF procedure in real time PROBLEM: QMFF & QM/MM Ewald sums that are stable with minimal basis sets blow up periodically with medium to large basis sets (e.g., 6-31G*). Total disaster. Sad! QM/MM Electrostatics: Background Ambient-Potential Composite Ewald (cEw) method Giese and York, J. Chem. Theory Comput. 12, 2611 (2016) Example mDC simulation of dimethyl glycine crystals (18-unit supercell, 288 residues, 4608 atoms, 10 ns) Framework is general for other QM methods (or mixed methods). Moving toward applications to kinases/phosphatases (including membranes), spectroscopy (IR, Raman, NMR) and new tools to facilitate drug discovery and process pipelines. Giese et al., J. Chem. Theory Comput. 11, 436 (2015); 11, 451 (2015). pmemdGTI: a GPU-accelerated free energy module in AMBER TI results are the L51a to L51bt mutation in Factor Xa in explicit solvent (41,563 total atoms) in the NVT ensemble using a 1 fs time step and PME electrostatics with the whole ligand defined as the TI region. T.-S. Lee et al. J Chem. Theory Comput. 13, 3077 (2017). Cleavage Transesterification Catalyzed by Twister Ribozyme • small nucleolytic ribozyme • What is the catalytically active state • mutational studies suggest that G33 in solution? and A1 may play the roles of a • What residues act as general acid general base and acid, respectively and base? • N3 position rather than N1 of A1 • How does the active site provide implicated in acid step electrostatic stabilization? :B AH+ Crystallographic Structures Represent Inactive States Comparison of Crystal Structures - Active Site 4OJI 4QJH 4RGE 5DUN Liu, Y. et. al. Nat. Eiler, DR. et. al. Proc. Ren, A. et. al. Nat. Kosutic, M. et. al. Chem. Biol., 2014, Natl. Acad. Sci., 2014, Commun., 2014, v5, Angew. Chem. Int. Ed. v10, p739. v111, p13028. p5534. Engl., 2015, v54, p15128. • Current crystallographic structures represent static pictures of inactive states of the ribozyme in a crystal, obfuscating their functional interpretation. • There is need for a structural (and dynamical) model of the active states in solution that is consistent with the current body of experimental data. Crystal Simulation Captures both Structure and Dynamics ● Average MD1 and crystal2 monomers are almost identical (0.8 Å heavy-atom RMSD) ● MD fluctuations agree closely with experimental B-factors (R=0.90) ● MD explains small fluctuations of U-1 (re. 6) and disordered of residues 17-18. 1. Gaines CS and York DM J. Am. Chem. Soc., 2016, v138, p 3058. 2. Liu, Y. et. al. Nat. Chem. Biol., 2014, v10, p739. Crystal Structure is in an Inactive State ● 4OJI lacks the 2’OH nucleophile and has U-1 extruded from the active site. ● MD simulations suggest U-1 is trapped in an INACTIVE state by a crystal packing contact that leads to disruption of the scissile phosphate center. ● Nucleophile-phosphate distance (Dinl) and inline attack angle (θinl) have poor inline fitness (Dinl > 3.5 Å and θinl ~90 ). Gaines CS and York DM J. Am. Chem. Soc., 2016, v138, p 3058. Solution Simulations Reveal Active Dynamical Picture U-1 Conformational States in Solution Without the crystal packing contact, U-1 can rotate from an “extruded” state to be “stacked” under G33 or form a base “triple” with A34 and A19. The “stacked” and “triple” states represent plausible ACTIVE states in solution. Stacking State Impacts In-line Fitness and Key Hydrogen Bonds Transition State Mimic Simulations Give Insight into General Acid Catalysis Stacked TS mimic ● “Stacked” and “triple” states preserve hydrogen bond scaffold ● Interactions involving A1:N3, G33, and the scissile phosphate support roles as general acid and base Triple TS mimic ● Hydrogen bond between G33:N2 and non-bridging phosphoryl oxygen is consistent thio substitution data Free Energy Simulations provide Insight into the Origin of pKa Shifts of Nucleobase Residues Bevilacqua, Biochemistry, 42, 2259 (2003) Dissanyake, Biochemistry, 54, 1307 (2015) Gaines CS, York DM J. Am. Chem. Soc., 2016, v138, p 3058. Intrinsic Rate of Reaction PBE0/6-31G*, 70 QM atoms, ~44,000 MM atoms, 2.8 ps/day (30s/MD step) on 96 cores ~ 5 ns of cumulative sampling for a full 2D profile General Base - Phosphoryl Transfer Intrinsic Rate of Reaction PBE0/6-31G*, 70 QM atoms, ~44,000 MM atoms, 2.8 ps/day (30s/MD step) on 96 cores ~ 5 ns of cumulative sampling for a full 2D profile Phosphoryl Transfer – General Acid Kinetic Isotope Effects Survey: identification of transition states from kinetic isotope effects RNase A active site model 2.31 2.29 Angew. Chem. Int. Ed. 51, 647 (2012) PNAS 110, 13002 (2013) Curr. Opin. Chem. Biol. 21C, 96 (2014) Verification of the Transition State by KIE Predictions Non-enz: O2’: 0.997 O5’: 1.034 RNase A: O2’: 0.994 O5’: 1.014 Twister*: O2’: 0.997 O5’: 1.004 Role of Adenine: • Embedded in an electronegative pocket that shifts pKa values. • Act as a general acid: − at the N1 position (hairpin & VS) − at the N3 position (twister) – a feature thus far novel to the twister ribozyme.
Recommended publications
  • Nobel Laureates Endorse Joe Biden

    Nobel Laureates Endorse Joe Biden

    Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S.
  • Date: To: September 22, 1 997 Mr Ian Johnston©

    Date: To: September 22, 1 997 Mr Ian Johnston©

    22-SEP-1997 16:36 NOBELSTIFTELSEN 4& 8 6603847 SID 01 NOBELSTIFTELSEN The Nobel Foundation TELEFAX Date: September 22, 1 997 To: Mr Ian Johnston© Company: Executive Office of the Secretary-General Fax no: 0091-2129633511 From: The Nobel Foundation Total number of pages: olO MESSAGE DearMrJohnstone, With reference to your fax and to our telephone conversation, I am enclosing the address list of all Nobel Prize laureates. Yours sincerely, Ingr BergstrSm Mailing address: Bos StU S-102 45 Stockholm. Sweden Strat itddrtSMi Suircfatan 14 Teleptelrtts: (-MB S) 663 » 20 Fsuc (*-«>!) «W Jg 47 22-SEP-1997 16:36 NOBELSTIFTELSEN 46 B S603847 SID 02 22-SEP-1997 16:35 NOBELSTIFTELSEN 46 8 6603847 SID 03 Professor Willis E, Lamb Jr Prof. Aleksandre M. Prokhorov Dr. Leo EsaJki 848 North Norris Avenue Russian Academy of Sciences University of Tsukuba TUCSON, AZ 857 19 Leninskii Prospect 14 Tsukuba USA MSOCOWV71 Ibaraki Ru s s I a 305 Japan 59* c>io Dr. Tsung Dao Lee Professor Hans A. Bethe Professor Antony Hewlsh Department of Physics Cornell University Cavendish Laboratory Columbia University ITHACA, NY 14853 University of Cambridge 538 West I20th Street USA CAMBRIDGE CB3 OHE NEW YORK, NY 10027 England USA S96 014 S ' Dr. Chen Ning Yang Professor Murray Gell-Mann ^ Professor Aage Bohr The Institute for Department of Physics Niels Bohr Institutet Theoretical Physics California Institute of Technology Blegdamsvej 17 State University of New York PASADENA, CA91125 DK-2100 KOPENHAMN 0 STONY BROOK, NY 11794 USA D anni ark USA 595 600 613 Professor Owen Chamberlain Professor Louis Neel ' Professor Ben Mottelson 6068 Margarldo Drive Membre de rinstitute Nordita OAKLAND, CA 946 IS 15 Rue Marcel-Allegot Blegdamsvej 17 USA F-92190 MEUDON-BELLEVUE DK-2100 KOPENHAMN 0 Frankrike D an m ar k 599 615 Professor Donald A.
  • The Protein That Wasn't There: the Discovery of Ribozymes

    The Protein That Wasn't There: the Discovery of Ribozymes

    The Protein that Wasn't There: The Discovery of Ribozymes Introduction If we were challenged to describe, in layman's terms, what makes living matter different from non-living matter, I suspect that many of us would focus on nucleic acids. Their ability to encode information, to replicate, and their passage from one generation to the next is part and parcel of what makes life special. Ironically, if one examines an organism carefully and observes what makes it "alive," nucleic acids turn out to have very little direct effect on living matter. Whether an animal moves, breathes, digests, turns its head to look, or just blinks an eye, its actions depend far more on enzymes than they do on DNA. Enzymes in muscle produce movement, in nerve cells they open membrane channels that produce message-carrying impulses, throughout the body enzymes produce, store, and convert chemical energy from one form to another. Enzymes are biological catalysts. Enzymes, which lower the activation energies of chemical reaction, are responsible for just about every activity that we associate with living things. Indeed, enzymes even control the synthesis, replication, folding, and activation of DNA itself. What kinds of molecules are there marvelous enzymes? They are proteins, of course. Look at any biology text, high school or college (including pp. 74-76 of Biology by Miller and Levine), and you will find that they devote a generous amount of space (and lots of pictures) to the structure of proteins. They are loaded with terms like a- helix, b- sheet, prosthetic group, secondary structure, and so forth.
  • Open Letter to the American People

    Open Letter to the American People

    FOR IMMEDIATE RELEASE: October 18, 2016 AN OPEN LETTER TO THE AMERICAN PEOPLE The coming Presidential election will have profound consequences for the future of our country and the world. To preserve our freedoms, protect our constitutional government, safeguard our national security, and ensure that all members of our nation will be able to work together for a better future, it is imperative that Hillary Clinton be elected as the next President of the United States. Some of the most pressing problems that the new President will face — the devastating effects of debilitating diseases such as Alzheimer’s disease and cancer, the need for alternative sources of energy, and climate change and its consequences — require vigorous support for science and technology and the assurance that scientific knowledge will inform public policy. Such support is essential to this country’s economic future, its health, its security, and its prestige. Strong advocacy for science agencies, initiatives to promote innovation, and sensible immigration and education policies are crucial to the continued preeminence of the U.S. scientific work force. We need a President who will support and advance policies that will enable science and technology to flourish in our country and to provide the basis of important policy decisions. For these reasons and others, we, as U.S. Nobel Laureates concerned about the future of our nation, strongly and fully support Hillary Clinton to be the President of the United States. Peter Agre, Chemistry 2003 Carol W. Greider, Medicine 2009 Sidney Altman, Chemistry 1989 David J. Gross, Physics 2004 Philip W. Anderson, Physics 1977 Roger Guillemin, Medicine 1977 Kenneth J.
  • Federation of American Scientists

    Federation of American Scientists

    FEDERATION OF AMERICAN SCIENTISTS T: 202/546-3300 1717 K Street NW #209 Washington, DC 20036 www.fas.org F: 202/675-1010 [email protected] Board of Sponsors (Partial List) November 12, 2001 *Sidney Altman *Philip W. Anderson Hon Tom Daschle Hon J. Dennis Hastert *Kenneth J. Arrow *Julius Axelrod Senate Majority Leader Speaker of the House *David Baltimore *Baruj Benacerraf *Hans A. Bethe *J. Michael Bishop Hon Trent Lott Hon Richard Gephardt *Nicolaas Bloembergen *Norman Borlaug Senate Minority Leader House Minority Leader *Paul Boyer Ann Pitts Carter *Owen Chamberlain In the interest of national security we urge you to deny funding for any program, project, or Morris Cohen *Stanley Cohen activity that is inconsistent with the Anti-Ballistic Missile (ABM) Treaty. The tragic events Mildred Cohn *Leon N. Cooper of September 11 eliminated any doubt that America faces security needs far more substantial *E. J. Corey *James Cronin than a technically improbable defense against a strategically improbable Third World *Johann Deisenhofer ballistic missile attack. Ann Druyan *Renato Dulbecco John T. Edsall Paul R. Ehrlich Regarding the probable threat, the September 11 attacks have dramatized what has been George Field obvious for years: A primitive ICBM, with its dubious accuracy and reliability and bearing *Val L. Fitch *Jerome I. Friedman a clear return address, is unattractive to a terrorist and a most improbable delivery system for John Kenneth Galbraith *Walter Gilbert a terrorist weapon. Devoting massive effort and expense to countering the least probable *Donald Glaser and least effective threat would be unwise. *Sheldon L. Glashow Marvin L. Goldberger *Joseph L.
  • The 1989 Nobel Prize in Chemistry Goes to Sidney Altman and Thomas

    The 1989 Nobel Prize in Chemistry Goes to Sidney Altman and Thomas

    current eammsnts’ EUGENE GARFIELD IFJSI(TUTE FOR SC16NT(F(L lNf C) HMATl ON~ 3501 MA FIK6T ST PHILADELPHIA PA 19104 The 1989 Nobel Prize in Chemistry Goes to Sidney Alhmm and Thomas R. Cech for the Discovery of Enzymatic RNA Numt3er zy JUIY lb, IYYU The 1989 Nobel Prize in chemistry has been awarded to Sidney Altrnan and Thomas R. Cech for their discovery that RNA in living cells can function not onfy as a molecule of heredity, but also as a biocatalyst. A brief historical overview of the laureates’ work is presented, and citation data for their most-cited publications are examined. Research-front analysis highlights both scientists’ cen- trafit y to the field of RNA enzymology studies. The effect of the finding of RNA catafysis on origin- of-iife theories is also covered. In the late 1970s and early 1980s, two and cell timction have had to be rethought. researchers, working independently, made In the words of the Swedish Academy, a discovery that reversed a 50-year-old “Many chapters in our textbooks have to be dogma in biochemistry-that the triggering revised. ” 1 and acceleration (catalysis) of chemicrd reac- Future applications of catalytic RNA tions within living cells were the exclusive could include its use as gene shears to domain of protein molecules called en- destroy RNA molecules involved in viral zymes. Biophysicist Sidney Altman, Yale infections such as the common cold or University, New Haven, Connecticut, and AIDS, in producing genetically engineered, chemist Thomas R. Cech, University of disease-resistant agricultural plants, and, at Colorado, Boulder, found that ribonucleic some date, correcting certain hereditag dis- acid (RNA), traditionally considered to be eases in both animals and humans.
  • From MRC-Cambridge to Madison, Wisconsin

    From MRC-Cambridge to Madison, Wisconsin

    C HA P TER 5 From MRC-Cambridge to Madison, Wisconsin William Dove and Alexandra Shedlovsky McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI Figure 5.1. Bill Dove. Figure 5.2. Alexandra Shedlovsky. PROLOGue – a STYLE OF DOING SCIENCE Our experience in the early 1960s as postdoctoral fellows in the MRC Unit for Molecular Biology led to our understanding the following principle: science is effectively driven by an idea when the seed is nourished by dialogue between con- trasting outlooks. We shall share our experiences that illustrate this ‘core principle’ 57 MC.indd 57 07/05/2013 16:36:27 M E M ORIES AND C ONSEQUEN C ES by which the MRC unit thrived in that era. Since science does not function in a vacuum we include our perceptions of the cultural context that stimulated the growth of ideas through dialogue. This dialogue led to the remarkable edifice of molecular biology that emerged from the unit and its progeny around the world. Our comments are strictly matters of personal perception; however, Horace Judson’s Eighth Day of Creation gives a more global view of this and surrounding eras,1 while Sidney Altman wrote from a personal perspective of his experiences in the unit a decade later [‘RNA processing: a postdoc in a great laboratory’2]. Finally, the core principle is revealed in the essay written by the physical chemist John Platt [‘Strong Inference: Certain systematic methods of scientific thinking may produce much more rapid progress than others’3]. The messenger RNA experiments, the demonstration of the ‘triplet code’, and Marshall Nirenberg’s polyU encoding polyPhe experiment were all published by the middle of 1961.
  • List of Nobel Laureates 1

    List of Nobel Laureates 1

    List of Nobel laureates 1 List of Nobel laureates The Nobel Prizes (Swedish: Nobelpriset, Norwegian: Nobelprisen) are awarded annually by the Royal Swedish Academy of Sciences, the Swedish Academy, the Karolinska Institute, and the Norwegian Nobel Committee to individuals and organizations who make outstanding contributions in the fields of chemistry, physics, literature, peace, and physiology or medicine.[1] They were established by the 1895 will of Alfred Nobel, which dictates that the awards should be administered by the Nobel Foundation. Another prize, the Nobel Memorial Prize in Economic Sciences, was established in 1968 by the Sveriges Riksbank, the central bank of Sweden, for contributors to the field of economics.[2] Each prize is awarded by a separate committee; the Royal Swedish Academy of Sciences awards the Prizes in Physics, Chemistry, and Economics, the Karolinska Institute awards the Prize in Physiology or Medicine, and the Norwegian Nobel Committee awards the Prize in Peace.[3] Each recipient receives a medal, a diploma and a monetary award that has varied throughout the years.[2] In 1901, the recipients of the first Nobel Prizes were given 150,782 SEK, which is equal to 7,731,004 SEK in December 2007. In 2008, the winners were awarded a prize amount of 10,000,000 SEK.[4] The awards are presented in Stockholm in an annual ceremony on December 10, the anniversary of Nobel's death.[5] As of 2011, 826 individuals and 20 organizations have been awarded a Nobel Prize, including 69 winners of the Nobel Memorial Prize in Economic Sciences.[6] Four Nobel laureates were not permitted by their governments to accept the Nobel Prize.
  • Johnson.Speakers to 2017.17

    Johnson.Speakers to 2017.17

    Johnson Symposia 1986-2018 1986 ALEXANDER KLIBANOV KONRAD BLOCH STEPHEN FODOR ALBERT ESCHENMOSER GEORGE OLAH SIR DEREK BARTON CHI-HUEY WONG JOHN D. ROBERTS REINHARD HOFFMANN GILBERT STORK BRUCE AMES WILLIAM S. JOHNSON 1995 1987 DEREK BARTON DUILIO ARIGONI RON BRESLOW STEPHEN BENKOVIC ALBERT ESCHENMOSER RONALD BRESLOW ROBERT GRUBBS E. J. COREY RALPH HIRSCHMANN GILBERT STORK GEORGE OLAH PETER DERVAN RYOJI NOYORI E. THOMAS KAISER BARRY SHARPLESS JEAN-MARIE LEHN GILBERT STORK 1988 JOHN ROBERTS SAMUEL DANISHEFSKY 1996 DUDLEY WILLIAMS MARYE ANNE FOX PAUL BARTLETT JOEL HUFF KOJI NAKANISHI ERIC JACOBSEN DUILIO ARIGONI LARRY OVERMAN JEREMY KNOWLES GEORGE PETTIT K. BARRY SHARPLESS PETER SCHULTZ DONALD CRAM GREGORY VERDINE 1989 MAXINE SINGER JACK BALDWIN 1997 A. R. BATTERSBY STEPHEN BUCHWALD DAVID EVANS CHARLES CASEY ROBERT GRUBBS STEPHEN FESIK CLAYTON HEATHCOCK M. REZA GHADIRI KOJI NAKANISHI STEPHEN HANESSIAN R. NOYORI DANIEL KAHNE CHARLES SIH MARY LOWE GOOD 1990 JOANNE STUBBE ROBERT BERGMAN 1998 THOMAS CECH KEN HOUK ROALD HOFFMANN NED PORTER STUART SCHREIBER ANDREAS PFALTZ HERBERT BROWN MAURICE BROOKHART HENRY ERLICH SEAN LANCE K. C. NICOLAOU WILLIAM FENICAL E. VOGEL SIDNEY ALTMAN 1991 DUILIO ARIGONI HARRY ALLCOCK 1999 JEROME BERSON STEVEN BOXER DALE BOGER JOHN BRAUMAN WILLIAM JORGENSEN JAMES COLLMAN RALPH RAPHAEL CARL DJERASSI PETER SCHULTZ CHAITAN KHOSLA DIETER SEEBACH BARRY TROST CHRISTOPER WALSH ROBERT WAYMOUTH 1992 THOMAS WANDLESS JACQUELINE BARTON PAUL WENDER KLAUS BIEMANN 2000 RICHARD LERNER SCOTT DENMARK MANFRED REETZ JANINE COSSY ALEJANDRO ZAFFARONI DENNIS DOUGHERTY CLARK STILL JONATHAN ELLMAN J. FRASER STODDART JERROLD MEINWALD HISASHI YAMAMOTO EI-ICHI NEGISHI 1993 MASAKATSU SHIBASAKI PAUL EHRLICH BERND GIESE LOUIS HEGEDUS 2001 STEVEN LEY ROB ARMSTRONG JULIUS REBEK JON CLARDY F.
  • Thomas Cech CV

    Thomas Cech CV

    CURRICULUM VITAE Thomas R. Cech Education and Training B.A. in Chemistry, Grinnell College, Grinnell, Iowa 1970 Ph.D. in Chemistry, University of California, Berkeley with Prof. John E. Hearst 1975 Postdoctoral Fellow, Dept. of Biology, Massachusetts Institute of Technology with Prof. Mary Lou Pardue 1975-77 Positions University of Colorado Boulder Assistant Professor of Chemistry 1978-82 Associate Professor of Chemistry 1982-83 Professor of Chemistry and Biochemistry 1983- Professor of Molecular, Cellular and Developmental Biology (joint appointment) 1983- American Cancer Society Professor 1987- University of Colorado Anschutz Medical Campus Professor of Biochemistry and Molecular Genetics Member, CU Cancer Center 1988- Investigator, Howard Hughes Medical Institute 1988-99; 2009- University of Colorado Distinguished Professor 1990- President, Howard Hughes Medical Institute 2000-09 Director, University of Colorado BioFrontiers Institute (formerly the 2009- Colorado Initiative in Molecular Biotechnology) Honors and Awards National Science Foundation Graduate Fellow 1970-75 Public Health Service Research Fellow, National Cancer Institute 1975-77 Research Career Development Award, National Cancer Institute 1980-85 Passano Foundation Young Scientist Award 1984 Harrison Howe Award 1984 Guggenheim Fellow 1985-86 Pfizer Award in Enzyme Chemistry 1985 Esquire Magazine Register 1985 Denver Post Westerner of the Year 1986 U. S. Steel Award in Molecular Biology 1987 Member, National Academy of Sciences 1987 Honorary Degree, Doctor of Science, Grinnell College 1987 V. D. Mattia Award 1987 Member, American Academy of Arts and Sciences 1988 Newcombe-Cleveland Award, AAAS (with Arthur J. Zaug) 1988 Heineken Prize, Royal Netherlands Academy of Sciences 1988 Gairdner Foundation International Award 1988 Louisa Gross Horwitz Prize (with Phillip A.
  • Teenie Matlock Wins Young Investigator Award

    Teenie Matlock Wins Young Investigator Award

    September-October 2011 · Volume 20, Number 5 Teenie Matlock From the President Wins Young Investigator Award Research Conference in Transition igma Xi’s In my last letter I presented a Framework for Action that briefly 2011 Young described three core actions needed to enable long-term growth SInvestigator and achievements consistent with our Society’s mission and vision. Award goes to One of these core actions is the transition of our annual meeting and international cognitive scientist research conference format. I am very pleased that the transition of Sigma Xi that began Teenie Matlock at at the grassroots level of our chapters and regional meetings has positively impacted the the University of format for our November 2011 meeting and research conference. California, Merced. With your continued support, the time is indeed at hand when our proceedings at these She is an associate professor whose main line events will be re-focused on our core values of fostering cooperation among scientists of research is psycholinguistics. and engineers, promoting honor, integrity and honesty in all scientific activities, and Matlock is best known for her work on nurturing the next generation of zealous companions in research around the world. spatial language, especially motion verbs, The core of our Annual Meeting and International Research Conference in Raleigh, but in her latest research, she is investigating North Carolina, November 10-13, 2011 will include speakers and panels, featuring language in the political realm, specifically, prominent leaders in, institutions of higher education, government and private enterprise. how the linguistic details of campaign ads influence attitudes about electability.
  • Image-Brochure-LNLM-2020-LQ.Pdf

    Image-Brochure-LNLM-2020-LQ.Pdf

    NOBEL LAUREATES PARTICIPATING IN LINDAU EVENTS SINCE 1951 Peter Agre | George A. Akerlof | Kurt Alder | Zhores I. Alferov | Hannes Alfvén | Sidney Altman | Hiroshi Amano | Philip W. Anderson | Christian B. Anfinsen | Edward V. Appleton | Werner Arber | Frances H. Arnold | Robert J. Aumann | Julius Axelrod | Abhijit Banerjee | John Bardeen | Barry C. Barish | Françoise Barré-Sinoussi | Derek H. R. Barton | Nicolay G. Basov | George W. Beadle | J. Georg Bednorz | Georg von Békésy |Eric Betzig | Bruce A. Beutler | Gerd Binnig | J. Michael Bishop | James W. Black | Elizabeth H. Blackburn | Patrick M. S. Blackett | Günter Blobel | Konrad Bloch | Felix Bloch | Nicolaas Bloembergen | Baruch S. Blumberg | Niels Bohr | Max Born | Paul Boyer | William Lawrence Bragg | Willy Brandt | Walter H. Brattain | Bertram N. Brockhouse | Herbert C. Brown | James M. Buchanan Jr. | Frank Burnet | Adolf F. Butenandt | Melvin Calvin Thomas R. Cech | Martin Chalfie | Subrahmanyan Chandrasekhar | Pavel A. Cherenkov | Steven Chu | Aaron Ciechanover | Albert Claude | John Cockcroft | Claude Cohen- Tannoudji | Leon N. Cooper | Carl Cori | Allan M. Cormack | John Cornforth André F. Cournand | Francis Crick | James Cronin | Paul J. Crutzen | Robert F. Curl Jr. | Henrik Dam | Jean Dausset | Angus S. Deaton | Gérard Debreu | Petrus Debye | Hans G. Dehmelt | Johann Deisenhofer Peter A. Diamond | Paul A. M. Dirac | Peter C. Doherty | Gerhard Domagk | Esther Duflo | Renato Dulbecco | Christian de Duve John Eccles | Gerald M. Edelman | Manfred Eigen | Gertrude B. Elion | Robert F. Engle III | François Englert | Richard R. Ernst Gerhard Ertl | Leo Esaki | Ulf von Euler | Hans von Euler- Chelpin | Martin J. Evans | John B. Fenn | Bernard L. Feringa Albert Fert | Ernst O. Fischer | Edmond H. Fischer | Val Fitch | Paul J.